3rd Gen. Vaccine
(CVI-HBV-001)
Formulation3rd Gen. Ag, L-HBsAg + Alum
Test VaccinePrefilled syringe
Dose·RouteND/ IM, 3 injections
TargetHypo- & Non-responders
(2 dose vaccine)
Clinical TrialA single center, randomized, double blinded phase I/IIa exploratory study to evaluate reactogenicity, safety, immunogenicity and dose-response of a new hepatitis B vaccine in human adult
StageClinical trial Phase I / IIa (completed)
Competitor2nd Gen. HBV vaccine
Sci-B-Vac (SciVac)
Adjuvanted Vaccine
(CVI-HBV-002)
Formulation3rd Gen. Ag, L-HBsAg + L-pampo
Test Vaccine
Dose·RouteND/ IM
TargetImmuno-therapeutics for chronic carriers & patients
Clinical TrialMulti-center, open labeled phase I/IIa study to evaluate safety, tolerability and efficacy of a therapeutic hepatitis B vaccine in oral antiviral drug-treated chronic hepatitis B virus carriers
StageClinical trial Phase I/IIa (on-going)
CompetitorGSK223192A (GSK)
Fendrix (GSK), Heplisav (Dynavax)